Dr. Schwertschlag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3 Stone Ridge Rd
Beverly, MA 01915Phone+1 978-921-5237
Education & Training
Ruprecht Karl University Faculty of MedicineClass of 1975
Certifications & Licensure
MA State Medical License 1995 - 2026
VA State Medical License 1994 - 2026
IN State Medical License 2007 - 2025
NC State Medical License 2011 - 2025
Clinical Trials
- QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery Start of enrollment: 2018 Jun 29
Publications & Presentations
PubMed
- 38 citationsResults of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid ...Larry W. Moreland, Ron Gugliotti, Kevin King, Walter F. Chase, Michael H. Weisman
Arthritis Research. 2001-04-10 - 625 citationsAnti-interleukin-12 antibody for active Crohn's diseasePeter J. Mannon, Ivan J. Fuss, Lloyd Mayer, Charles O. Elson, William J. Sandborn
The New England Journal of Medicine. 2004-11-11 - 2 citationsPopulation pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants.Liviawati S Wu, Yue Hu, Edward J Gane, Leen Slaets, An De Creus
Antiviral Therapy. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
